Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer

Rui Xu; Hui Peng; Ning Yang; Zhenping Liu; Wei Lu

doi:10.1016/j.gendis.2021.12.018

您当前的位置：

首页 >

文章列表页 >

Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer

Short communication | 更新时间：2023-08-29

- Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer
- Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer
- Genes & Diseases 2023年10卷第1期
- 作者机构：
  
  1. Key Laboratory of Gynecologic Oncology of Shandong Province, Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University,Shandong,Jinan,China,250012
  2. Department of Clinical Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University,Shandong,Jinan,China,250021
  3. Department of Clinical Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong University,Shandong,Jinan,China,250021
  4. Department of Obstetrics and Gynecology, The Fifth People's Hospital of Jinan,Shandong,Jinan,China,250022
  5. Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University,Shandong,Jinan,China,250012
  6. Shandong Engineering Laboratory for Urogynecology, Qilu Hospital of Shandong University,Shandong,Jinan,China,250012
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2021.12.018
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-1-1，
扫描看全文
Rui Xu, Hui Peng, Ning Yang, 等. Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer[J]. Genes & Diseases, 2023,10(1).

Rui Xu, Hui Peng, Ning Yang, et al. Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer[J]. Genes & Diseases, 2023,10(1).
Rui Xu, Hui Peng, Ning Yang, 等. Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer[J]. Genes & Diseases, 2023,10(1). DOI： 10.1016/j.gendis.2021.12.018.

Rui Xu, Hui Peng, Ning Yang, et al. Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer[J]. Genes & Diseases, 2023,10(1). DOI： 10.1016/j.gendis.2021.12.018.

摘要

Abstract

关键词

Keywords

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据

Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer

Nuclear lncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer

DOI：10.1016/j.gendis.2021.12.018

摘要

Abstract

关键词

Keywords

references